In The News

Financial Times – Alzheimer’s drug revival gives hope to millions — and investors

STAT – Biogen’s good news on aducanumab could ‘open the floodgates’ for Alzheimer’s drugs

The Big Biz Show – Interview with Dr. Elliot Goldstein

European Biopharmaceutical Review July 2019

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Ending Parkinson’s disease: The path is getting shorter

Alzheimer’s Disease is a ‘Double-Prion Disorder,’ Study Shows

Guest Commentary: Targeting α-synuclein and the pathogenesis of Parkinson’s disease

Attacking the Right Therapeutic Target in Alzheimer’s Disease

Could Roche’s Alzheimer’s drug failure be Promis Neurosciences gain?